Skip to main content
. 2024 Aug 3;16(8):e66088. doi: 10.7759/cureus.66088

Table 4. Clinical outcomes .

IQR: Interquartile range

Outcome Bladder Neoplasms (n = 174)
Treatment response, n (%)
-Complete remission 132 (75.9)
-Partial response 36 (20.7)
-No response 6 (3.4)
Recurrence rate, n (%)
-Yes 28 (16.1)
-No 146 (83.9)
Overall survival (months), median (IQR)
-Urothelial carcinoma 48 (36-60)
-Squamous cell carcinoma 24 (18-36)
-Adenocarcinoma 18 (12-24)